PITHA V. MULLER et al. - Page 18




          Interference 102,413                                      Page 18           
          Pitha v. Muller                                                             
               An actual reduction to practice requires proof of the                  
          existence of a physical embodiment within the scope of the                  
          count. Correge v. Murphy, 705 F.2d 1326, 1329, 217 USPQ 753,                
          755 (Fed. Cir. 1983).  The embodiment relied upon for an                    
          actual reduction to practice must include every limitation                  
          stated in the count. Schendel v. Curtis, 83 F.3d 1399, 1402,                
          38 USPQ2d 1743, 1746 (Fed. Cir. 1996).  The evidence must also              
          show that the embodiment is suitable for and actually worked                
          for its intended purpose.  Scott v. Finney, 34 F.3d 1058,                   
          1061, 32 USPQ2d 1115, 1118 (Fed. Cir. 1994).  Testing need not              
          show utility beyond a possibility of failure, but only utility              
          beyond a probability of failure.  Scott, 34 F.3d at 1061-62,                
          32 USPQ2d at 1118.  There is no requirement that the                        
          embodiment be in a "commercially satisfactory stage of                      
          development" to constitute a reduction to practice.  Scott, 34              
          F.3d at 1063, 32 USPQ2d at 1118.                                            
               The sole count in this interference follows:                           
                                       Count 3                                        
               A method of producing a stabilized amorphous complex                   
               of  a  drug  and  a mixture  of  cyclodextrins  which                  
               comprises the steps of:                                                
                    1.  Dissolving an intrinsically amorphous mixture                 
                    of  cyclodextrin  derivatives  which  are  water                  
                    soluble  and  capable  of  forming  inclusion                     
                    complexes with drugs in water; and                                







Page:  Previous  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  Next 

Last modified: November 3, 2007